NCT00637091 2021-01-22Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) ExpressionsAsan Medical CenterPhase 2 Completed40 enrolled
NCT00309179 2017-09-14A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid TumorsEisai Inc.Phase 2 Completed41 enrolled